Wormentel 222mg contains Fenbendazole 222mg, an antiparasitic compound belonging to the benzimidazole class.

Fenbendazole acts against susceptible parasites by interfering with tubulin and microtubule formation, as well as processes involved in glucose uptake and energy metabolism. These effects impair essential cellular functions of susceptible parasites.

Veterinary fenbendazole products can be indicated for different parasitic infections depending on the animal species and formulation, including certain gastrointestinal nematode infections.

The 222mg strength represents the stated amount of fenbendazole in the product. It should not be interpreted as a universal dose for every animal or parasite.

Product Information

Veterinary Uses

Fenbendazole may be used in veterinary medicine against susceptible parasitic worms, depending on the approved product and animal species.

Potential veterinary targets can include certain:

• Gastrointestinal roundworms
• Hookworms
• Whipworms
• Other susceptible nematode parasites

The exact approved indications vary by species, formulation, and jurisdiction.

How Fenbendazole Works

Fenbendazole is a benzimidazole anthelmintic.

It interferes with parasite tubulin and microtubule-dependent processes, affecting:

1. Microtubule formation
2. Nutrient uptake
3. Glucose utilization
4. Energy metabolism

This disruption interferes with the parasite’s ability to survive and contributes to its elimination.

Dosage and Administration

Do not publish a universal dosing schedule for Wormentel 222mg without the manufacturer’s veterinary label.

Veterinary dosing can depend on:

• Animal species
• Body weight
• Parasite being treated
• Infection severity
• Product formulation
• Treatment duration

The appropriate regimen should be determined from the specific veterinary product label or by a veterinarian.

The 222mg strength alone does not establish the correct dose for an individual animal.

Veterinary Safety Information

Fenbendazole should be administered according to the applicable veterinary product labeling.

Do not:

• Exceed the labeled dose
• Extend treatment beyond the labeled duration without veterinary direction
• Use an animal formulation as a substitute for a human medicine
• Assume a dose intended for one animal species is appropriate for another

The FDA has reported adverse-event concerns associated with extra-label prolonged fenbendazole use in dogs, including reports of bone-marrow hypoplasia and pancytopenia.

Product Highlights

• Active Ingredient: Fenbendazole
• Strength: 222mg
• Drug Class: Benzimidazole anthelmintic
• Product Category: Veterinary antiparasitic
• Used against susceptible parasitic worms in appropriate animal species
• Species-specific dosing required
• Follow the applicable veterinary label
• Animal Use Only